AGTC - Applied Genetic Technologies Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
6/29/2019
6/29/2018
6/29/2017
6/29/2016
Total Revenue
27,658
41,692
24,186
39,473
47,361
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
31,760
33,183
32,181
26,217
38,864
Selling General and Administrative
12,994
12,859
14,389
11,354
10,586
Total Operating Expenses
44,754
46,042
46,570
37,571
49,450
Operating Income or Loss
-17,096
-4,350
-22,384
1,902
-2,089
Interest Expense
-
-
-
0
-
Total Other Income/Expenses Net
2,430
2,455
1,176
905
708
Income Before Tax
-14,668
-1,895
-21,208
2,807
-1,381
Income Tax Expense
78
76
72
2,400
-
Income from Continuing Operations
-14,783
-2,006
-21,300
407
-1,381
Net Income
-14,783
-2,006
-21,300
407
-1,381
Net Income available to common shareholders
-14,783
-2,006
-21,300
407
-1,381
Reported EPS
Basic
-
-0.11
-1.18
0.02
-0.08
Diluted
-
-0.11
-1.18
0.02
-0.08
Weighted average shares outstanding
Basic
-
18,157
18,105
18,072
17,810
Diluted
-
18,157
18,105
18,385
17,810
EBITDA
-
-4,350
-22,384
1,902
-1,522